Akums Drugs & Pharmaceuticals IPO Subscription Status
Akums Drugs & Pharmaceuticals IPO was subscribed 63.44 times when bidding closed on 1 Aug 2024: QIB 90.09x, NII 42.1x, Retail 20.8x.
The Akums Drugs & Pharmaceuticals IPO has been subscribed 63.44x times overall. Retail investors have shown interest with bids for 20.8x the shares available. The Non-Institutional Investor (NII) category has been subscribed 42.1x. Within NII, Big HNI (B-HNI) subscribed 47.43x and Small HNI (S-HNI) subscribed 31.45x. Qualified Institutional Buyers (QIBs) have subscribed 90.09x. Data last updated on 10 Nov, 06:45 PM.
The IPO subscription period has ended. Given the strong demand, the allotment process is expected to be highly competitive. The issue opened on 30 Jul, 2024 and closes on 01 Aug, 2024. The shares are expected to list on stock exchanges on 06 Aug, 2024.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Live bidding
Shares bid against shares offered, category by category, as published by the exchanges. Summary splits NII into bHNI (above ₹10 lakh) and sHNI (₹2–10 lakh); switch to Detailed for the exchange's own sub-category rows.
| Category | Bid details | Times |
|---|---|---|
| QIB | - of - - | 90.09x |
| NII | - of - - | 42.1x |
bHNI — bid amount above ₹10 Lakh |
- - | 47.43 |
sHNI — bid amount ₹2–10 Lakh |
- - | 31.45 |
| Retail | - of - - | 20.8x |
| Employee | - of - - | 4.14x |
| TOTAL | - - | 63.44x |
Akums Drugs & Pharmaceuticals IPO allotment probability
Your odds of an allotment in each category at the current subscription.
Odds = allotment slots ÷ applications, or the subscription multiple where counts aren't available. Retail and HNI allotment is by lottery; QIB is proportionate. Not investment advice.
Subscription insights
What the current book is saying, read off the category numbers above.
Retail Allotment
High demand detected. The retail category is heavily oversubscribed, making the allotment a lottery where only 1 out of every 21 applicants will be successful.
Institutional Backing
Massive institutional interest with QIBs subscribing 90.09x. This often signals long-term confidence from professional funds.
Day-wise subscription history
End-of-day subscription across the 3-day bidding window. On phones, tap a day for the category split.
| Date | Total | ||
|---|---|---|---|
|
01 Aug 2024
Day 3 |
63.44x | ▼ | |
|
QIB90.09x
BHNI47.43x
SHNI31.45x
Retail20.8x
Employee4.14x
|
|||
|
31 Jul 2024
Day 2 |
4.43x | ▼ | |
|
QIB0.96x
BHNI8.87x
SHNI7.7x
Retail8.98x
|
|||
|
30 Jul 2024
Day 1 |
1.37x | ▼ | |
|
QIB0.43x
BHNI2.04x
SHNI1.8x
Retail3.35x
|
|||
Akums Drugs & Pharmaceuticals IPO dates
From the bidding window to listing. Today is 11 November.
- Open 30 Jul 2024
- Close 01 Aug 2024
- Allotment 02 Aug 2024
- Refund/credit 05 Aug 2024
- Listing 06 Aug 2024
What does this subscription data mean?
IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:
- 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
- 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
- 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
- 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.
Data sourced from BSE/NSE. Subscription numbers are updated during bidding hours (10 AM – 5 PM IST) on active subscription days.
Frequently asked
What is the current subscription status of Akums Drugs & Pharmaceuticals IPO?
As of IPO close date (01 Aug, 2024), the Akums Drugs & Pharmaceuticals IPO is subscribed 63.44x times. Retail category is 20.8x, and NII is 42.1x subscribed.
When is the allotment date for Akums Drugs & Pharmaceuticals IPO?
The allotment for Akums Drugs & Pharmaceuticals IPO is expected to be finalized on 02 August, 2024.
What is the GMP of Akums Drugs & Pharmaceuticals?
The Grey Market Premium (GMP) for Akums Drugs & Pharmaceuticals is currently ₹40, indicating a potential listing gain of 6%.
When will Akums Drugs & Pharmaceuticals IPO list on the stock market?
Akums Drugs & Pharmaceuticals is scheduled to list on BSE and NSE on 06 August, 2024.
What are the chances of getting allotment in Akums Drugs & Pharmaceuticals IPO?
The retail category is oversubscribed at 20.8x, meaning allotment is by lottery. Statistically, approximately 1 in 21 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.
What does QIB subscription of 90.09x mean for Akums Drugs & Pharmaceuticals IPO?
Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 90.09x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.
How to check Akums Drugs & Pharmaceuticals IPO allotment status?
After the allotment date (02 Aug, 2024), you can check your Akums Drugs & Pharmaceuticals IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.
Explore Akums Drugs & Pharmaceuticals IPO further
Track every stage of this IPO, from subscription to listing.
It has listed — go back to the fundamentals.
Live grey market premium, Kostak and Subject to Sauda, with the day-wise trend.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
Subscription moves by the hour. Get it on your phone.
Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.
Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.
